ReviewJournal of diabetes science and technology2010

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone.

Andreas Pfützner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.